美国FDA药品数据库（U.S. FDA Drugs Database）
检索条件:" 药品名称=LEVOMILNACIPRAN"
符合检索条件的记录共 24 条
共 2 页，当前第 1 页
下一页 最后一页 返回检索页 可点击列名称排序
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
LEVOMILNACIPRAN HYDROCHLORIDE 210790 001 ANDA LEVOMILNACIPRAN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EQ 20MG BASE No No 2019/02/04 2019/02/04 AMNEAL PHARMS CO Discontinued
LEVOMILNACIPRAN HYDROCHLORIDE 210790 002 ANDA LEVOMILNACIPRAN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EQ 40MG BASE No No 2019/02/04 2019/02/04 AMNEAL PHARMS CO Discontinued
LEVOMILNACIPRAN HYDROCHLORIDE 210790 003 ANDA LEVOMILNACIPRAN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EQ 80MG BASE No No 2019/02/04 2019/02/04 AMNEAL PHARMS CO Discontinued
LEVOMILNACIPRAN HYDROCHLORIDE 210790 004 ANDA LEVOMILNACIPRAN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EQ 120MG BASE No No 2019/02/04 2019/02/04 AMNEAL PHARMS CO Discontinued
LEVOMILNACIPRAN 210805 001 ANDA LEVOMILNACIPRAN CAPSULE, EXTENDED RELEASE;ORAL 20MG No No 2020/06/01 (TA) -- MSN LABORATORIES PRIVATE LTD None (Tentative Approval)
LEVOMILNACIPRAN 210805 002 ANDA LEVOMILNACIPRAN CAPSULE, EXTENDED RELEASE;ORAL 40MG No No 2020/06/01 (TA) -- MSN LABORATORIES PRIVATE LTD None (Tentative Approval)
LEVOMILNACIPRAN 210805 003 ANDA LEVOMILNACIPRAN CAPSULE, EXTENDED RELEASE;ORAL 80MG No No 2020/06/01 (TA) -- MSN LABORATORIES PRIVATE LTD None (Tentative Approval)
LEVOMILNACIPRAN 210805 004 ANDA LEVOMILNACIPRAN CAPSULE, EXTENDED RELEASE;ORAL 120MG No No 2020/06/01 (TA) -- MSN LABORATORIES PRIVATE LTD None (Tentative Approval)
LEVOMILNACIPRAN HYDROCHLORIDE 210732 001 ANDA LEVOMILNACIPRAN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EQ 20MG BASE No No 2020/11/05 2020/11/05 HIKMA Discontinued
LEVOMILNACIPRAN HYDROCHLORIDE 210732 002 ANDA LEVOMILNACIPRAN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EQ 40MG BASE No No 2020/11/05 2020/11/05 HIKMA Discontinued
LEVOMILNACIPRAN HYDROCHLORIDE 210732 003 ANDA LEVOMILNACIPRAN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EQ 80MG BASE No No 2020/11/05 2020/11/05 HIKMA Discontinued
LEVOMILNACIPRAN HYDROCHLORIDE 210732 004 ANDA LEVOMILNACIPRAN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EQ 120MG BASE No No 2020/11/05 2020/11/05 HIKMA Discontinued
LEVOMILNACIPRAN HYDROCHLORIDE 210826 001 ANDA LEVOMILNACIPRAN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EQ 20MG BASE No No 2023/01/06 2023/01/06 AUROBINDO PHARMA LTD Discontinued
LEVOMILNACIPRAN HYDROCHLORIDE 210826 002 ANDA LEVOMILNACIPRAN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EQ 40MG BASE No No 2023/01/06 2023/01/06 AUROBINDO PHARMA LTD Discontinued
LEVOMILNACIPRAN HYDROCHLORIDE 210826 003 ANDA LEVOMILNACIPRAN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EQ 80MG BASE No No 2023/01/06 2023/01/06 AUROBINDO PHARMA LTD Discontinued
LEVOMILNACIPRAN HYDROCHLORIDE 210826 004 ANDA LEVOMILNACIPRAN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EQ 120MG BASE No No 2023/01/06 2023/01/06 AUROBINDO PHARMA LTD Discontinued
LEVOMILNACIPRAN 210857 001 ANDA LEVOMILNACIPRAN CAPSULE, EXTENDED RELEASE;ORAL 20MG No No 2023/01/12 (TA) -- ZYDUS PHARMS USA INC None (Tentative Approval)
LEVOMILNACIPRAN 210857 002 ANDA LEVOMILNACIPRAN CAPSULE, EXTENDED RELEASE;ORAL 40MG No No 2023/01/12 (TA) -- ZYDUS PHARMS USA INC None (Tentative Approval)
LEVOMILNACIPRAN 210857 003 ANDA LEVOMILNACIPRAN CAPSULE, EXTENDED RELEASE;ORAL 80MG No No 2023/01/12 (TA) -- ZYDUS PHARMS USA INC None (Tentative Approval)
LEVOMILNACIPRAN 210857 004 ANDA LEVOMILNACIPRAN CAPSULE, EXTENDED RELEASE;ORAL 120MG No No 2023/01/12 (TA) -- ZYDUS PHARMS USA INC None (Tentative Approval)
药品名称，活性成分，申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database